CASZ1: a promising factor modulating aldosterone biosynthesis and mineralocorticoid receptor activity
CASZ1: a promising factor modulating aldosterone biosynthesis and mineralocorticoid receptor activity
复制标题
DOI:
10.1038/s41440-022-01131-8
复制
发表时间:
2022-12
影响因子:
5.4
通讯作者:
K. Yokota;H. Shibata;I. Kurihara;H. Itoh;Masakatsu Sone
中科院分区:
文献类型:
--
作者:
K. Yokota;H. Shibata;I. Kurihara;H. Itoh;Masakatsu Sone
Hypertension is the definitive risk factor for cardiovascular disease. Primary aldosteronism (PA), a typical form of secondary hypertension, is responsible for treatment-resistant hypertension and carries an even higher risk of causing cardiovascular complications than essential hypertension. Several genes involved in the pathogenesis of hypertension have been identified recently using genome-wide association studies (GWASs). Among these, castor zinc finger 1(CASZ1) is considered to be involved in the pathophysiology of hypertension via modulation of aldosterone action. In 2021, using a biochemical approach with liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis, we identified CASZ1b, an isoform of CASZ1, as a novel mineralocorticoid receptor (MR) coregulator. Our further analysis revealed that CASZ1b is coexpressed with MR in MR targets such as kidney tubule cells, and that a decrease in CASZ1 protein levels promotes aldosterone-dependent transcriptional activity of MR. Further, a recent study of GWAS on PA identifiedCASZ1to be a PA-related gene and demonstrated that overexpression of CASZ1 suppresses aldosterone biosynthesis in adrenal cells. These results suggest CASZ1 plays a pivotal role in the pathophysiology of hypertension and PA via dual mechanisms: aldosterone biosynthesis and transcriptional activity of MR.